List of Emergex Vaccines Holding Limited patents

List of Emergex Vaccines Holding Limited patents

List of Mead Johnson Nutrition patents

List of Elkay Manufacturing patents

List of Teleflex Medical patents

List of awards received by Mike Leigh

List of awards received by Rui Patrício

Patents where

Current Assignee

Name

is

Emergex Vaccines Holding Limited

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11344614 Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes	Patent 11344614 was granted and assigned to Emergex Vaccines Holding Limited on May, 2022 by the United States Patent and Trademark Office.	Emergex Vaccines Holding Limited	Emergex Vaccines Holding Limited		United States Patent and Trademark Office	11344614	May 31, 2022
	‌ US Patent 11273216 Universal influenza vaccine compositions	Patent 11273216 was granted and assigned to Emergex Vaccines Holding Limited on March, 2022 by the United States Patent and Trademark Office.	Emergex Vaccines Holding Limited	Emergex Vaccines Holding Limited		United States Patent and Trademark Office	11273216	March 15, 2022
	‌ US Patent 11426457 MHC class I associated peptides for prevention and treatment of zika virus		Emergex Vaccines Holding Limited	Emergex Vaccines Holding Limited		United States Patent and Trademark Office	11426457	August 30, 2022
	‌ US Patent 10117922 Dengue virus specific multiple HLA binding T cell epitopes for the use of universal vaccine development	Patent 10117922 was granted and assigned to Emergex Vaccines Holding Limited on November, 2018 by the United States Patent and Trademark Office.	Emergex Vaccines Holding Limited	Emergex Vaccines Holding Limited		United States Patent and Trademark Office	10117922	November 6, 2018
	‌ US Patent 11191828 MHC class I associated hepatitis B peptides	Patent 11191828 was granted and assigned to Emergex Vaccines Holding Limited on December, 2021 by the United States Patent and Trademark Office.	Emergex Vaccines Holding Limited	Emergex Vaccines Holding Limited		United States Patent and Trademark Office	11191828	December 7, 2021
	‌ US Patent 10155036 MHC class I associated peptides for prevention and treatment of hepatitis B virus infection	Patent 10155036 was granted and assigned to Emergex Vaccines Holding Limited on December, 2018 by the United States Patent and Trademark Office.	Emergex Vaccines Holding Limited	Emergex Vaccines Holding Limited		United States Patent and Trademark Office	10155036	December 18, 2018
	‌ US Patent 10556929 Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection	Patent 10556929 was granted and assigned to Emergex Vaccines Holding Limited on February, 2020 by the United States Patent and Trademark Office.		Emergex Vaccines Holding Limited		United States Patent and Trademark Office	10556929	February 11, 2020
	‌ US Patent 10144766 Cytotoxic T Lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection	Patent 10144766 was granted and assigned to Emergex Vaccines Holding Limited on December, 2018 by the United States Patent and Trademark Office.		Emergex Vaccines Holding Limited		United States Patent and Trademark Office	10144766	December 4, 2018

8 results

0 selected

8 results

0 selected